Predictors of PAH | OR (95Â % CI) | p |
---|---|---|
GAVE | 1.42 (0.8–2.5) | 0.21 |
Reflux oesphagitis | 1.07 (0.8–1.5) | 0.71 |
Oesphageal stricture | 2.59 (1.7–4.0) | <0.001 |
Oesphageal dysmotility | 1.43 (0.8–2.5) | 0.20 |
Bowel dysmotility | 1.47 (1.0–2.2) | 0.05 |
Anal incontinence | 1.66 (1.1–2.5) | 0.01 |
Myocardial | 1.14 (0.6–2.2) | 0.70 |
Pericardial effusion | 4.44 (2.7–7.4) | <0.001 |
Renal crisis | 0.59 (0.2–2.5) | 0.47 |
Synovitis | 0.96 (0.6–1.5) | 0.86 |
Joint contractures | 1.79 (1.2–2.6) | 0.002 |
Calcinosis | 2.65 (1.8–3.9) | <0.001 |
Digital Ulcers | 1.85 (1.3–2.7) | 0.001 |
Sicca symptoms | 2.23 (1.5–3.4) | <0.001 |
ILD | 1.95 (1.4–2.8) | <0.001 |
Telangiectasia | 3.02 (1.5–6.0) | 0.002 |
Disease duration at recruitment | 1.03 (1.01–1.05) | <0.001 |
Limited systemic sclerosis | 1.13 (0.8–1.7) | 0.54 |
Autoantibodies | ||
 Anti-centromere pattern | 1.36 (0.9–1.9) | 0.11 |
 Scl 70 + ve | 0.49 (0.2–0.9) | 0.05 |
 RNA polymerase III + ve | 0.89 (0.4–1.9) | 0.78 |